期刊
OSTEOPOROSIS INTERNATIONAL
卷 29, 期 12, 页码 2585-2596出版社
SPRINGER LONDON LTD
DOI: 10.1007/s00198-018-4650-2
关键词
Diabetes; Diabetes-related bone disease; Fracture; Osteoporosis
资金
- MRC [G0400491, MC_UU_12011/2, MC_U147585827, MC_UP_A620_1015, MC_U147585819, MR/P020941/1] Funding Source: UKRI
- Medical Research Council [G0601019] Funding Source: researchfish
- Medical Research Council [MC_UP_A620_1015, MC_U147585824, G0400491, MR/P020941/1, MC_UU_12011/1, MC_UP_A620_1014, MC_U147585819, MC_UU_12011/2, MC_U147585827] Funding Source: Medline
- Department of Health [10/33/04] Funding Source: Medline
Fragility fractures are increasingly recognized as a complication of both type 1 and type 2 diabetes, with fracture risk that increases with disease duration and poor glycemic control. Yet the identification and management of fracture risk in these patients remains challenging. This review explores the clinical characteristics of bone fragility in adults with diabetes and highlights recent studies that have evaluated bone mineral density (BMD), bone microstructure and material properties, biochemical markers, and fracture prediction algorithms (i.e., FRAX) in these patients. It further reviews the impact of diabetes drugs on bone as well as the efficacy of osteoporosis treatments in this population. We finally propose an algorithm for the identification and management of diabetic patients at increased fracture risk.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据